Linda Rainey1, Daniëlle van der Waal1, Yvonne Wengström2,3, Anna Jervaeus2, Mireille J M Broeders1,4. 1. a Radboud Institute for Health Sciences, Radboud University Medical Center , Nijmegen , The Netherlands. 2. b Department of Neurobiology, Care Sciences and Society, Division of Nursing , Karolinska Institutet , Huddinge , Sweden. 3. c Theme Cancer, Karolinska University Hospital , Huddinge , Sweden. 4. d Dutch Expert Center for Screening , Nijmegen , The Netherlands.
Abstract
INTRODUCTION: Increased knowledge of breast cancer risk factors may enable a paradigm shift from the current age-based mammographic screening programmes to a personalised risk-based approach. This would warrant a significant change in practice, yet the acceptability from a woman's perspective has never been systematically explored. In this systematic review, we inventoried and appraised studies of women's perceptions of risk-based breast cancer screening and prevention to identify factors associated with adopting this new paradigm. METHODS: We searched Medline, Embase and PsycInfo to identify original articles in English containing perceptions of risk-based breast cancer screening and/or primary prevention of women with an average to above average risk of developing breast cancer. Qualitative data were systematically extracted and referenced against four theoretical models of preventative health behaviour adoption. RESULTS: When considering the adoption of this novel screening and prevention programme, women carefully review their perceived susceptibility to breast cancer. Their decisions are based on a cost-benefit analysis of adopting lifestyle changes, chemoprevention, or prophylactic surgery, taking into account their perceived competence, individual autonomy, relatedness to others, and personal preference. The role of intent is limited when considering behavioural change. CONCLUSIONS: Implementing risk-based breast cancer screening and prevention will require a multifactorial approach. The transition from theory to practice can be supported by developing evidence-based shared decision aids and family-oriented (genetic) counselling programmes.
INTRODUCTION: Increased knowledge of breast cancer risk factors may enable a paradigm shift from the current age-based mammographic screening programmes to a personalised risk-based approach. This would warrant a significant change in practice, yet the acceptability from a woman's perspective has never been systematically explored. In this systematic review, we inventoried and appraised studies of women's perceptions of risk-based breast cancer screening and prevention to identify factors associated with adopting this new paradigm. METHODS: We searched Medline, Embase and PsycInfo to identify original articles in English containing perceptions of risk-based breast cancer screening and/or primary prevention of women with an average to above average risk of developing breast cancer. Qualitative data were systematically extracted and referenced against four theoretical models of preventative health behaviour adoption. RESULTS: When considering the adoption of this novel screening and prevention programme, women carefully review their perceived susceptibility to breast cancer. Their decisions are based on a cost-benefit analysis of adopting lifestyle changes, chemoprevention, or prophylactic surgery, taking into account their perceived competence, individual autonomy, relatedness to others, and personal preference. The role of intent is limited when considering behavioural change. CONCLUSIONS: Implementing risk-based breast cancer screening and prevention will require a multifactorial approach. The transition from theory to practice can be supported by developing evidence-based shared decision aids and family-oriented (genetic) counselling programmes.
Authors: Linda Rainey; Anna Jervaeus; Louise S Donnelly; D Gareth Evans; Mattias Hammarström; Per Hall; Yvonne Wengström; Mireille J M Broeders; Daniëlle van der Waal Journal: Psychooncology Date: 2019-03-25 Impact factor: 3.894
Authors: Victoria G Woof; Helen Ruane; David P French; Fiona Ulph; Nadeem Qureshi; Nasaim Khan; D Gareth Evans; Louise S Donnelly Journal: BMC Cancer Date: 2020-05-20 Impact factor: 4.430
Authors: Linda Rainey; Daniëlle van der Waal; Louise S Donnelly; Jake Southworth; David P French; D Gareth Evans; Mireille J M Broeders Journal: BMC Cancer Date: 2022-01-16 Impact factor: 4.430
Authors: Lorna McWilliams; Victoria G Woof; Louise S Donnelly; Anthony Howell; D Gareth Evans; David P French Journal: BMC Cancer Date: 2021-05-29 Impact factor: 4.430
Authors: Linda Rainey; Daniëlle van der Waal; Anna Jervaeus; Louise S Donnelly; D Gareth Evans; Mattias Hammarström; Per Hall; Yvonne Wengström; Mireille J M Broeders Journal: BMC Cancer Date: 2020-03-24 Impact factor: 4.430
Authors: Andrea Martínez-Urquijo; Álvaro Postigo; Marcelino Cuesta; María Del Mar Fernández-Álvarez; Rubén Martín-Payo Journal: Cancer Causes Control Date: 2021-07-08 Impact factor: 2.506